Podcast Beta
Questions and Answers
What gene encodes Nav1.5?
Which syndrome is associated with gain-of-function mutations in SCN5A?
What characteristic feature can occur spontaneously in Brugada syndrome?
Which of the following is a known result of gain-of-function mutations in SCN5A in Type 3 Long QT syndrome?
Signup and view all the answers
What recent gene was identified as being responsible for Brugada syndrome?
Signup and view all the answers
What effect do sodium-channel blockers have on Brugada syndrome?
Signup and view all the answers
What technique is used for quantifying electrophysiological changes in whole tissues or hearts?
Signup and view all the answers
Which syndrome is NOT listed as a genetic polymorphism associated with SCN5A?
Signup and view all the answers
What is the primary function of Nav1.5 in the human heart?
Signup and view all the answers
Which statement best describes Nav1.5?
Signup and view all the answers
What clinical implications can arise from genetic polymorphisms in SCN5A?
Signup and view all the answers
Which experimental technique is appropriate to explore cardiac electrophysiology?
Signup and view all the answers
What effect does the familial atrial fibrillation mutation M1875T-SCN5A have on sodium current?
Signup and view all the answers
Which publication is associated with new Brugada syndrome risk loci?
Signup and view all the answers
What is NOT a characteristic of Nav1.5?
Signup and view all the answers
What is one of the biophysical properties of Nav1.5?
Signup and view all the answers
What is a consequence of using anti-arrhythmic drugs with a narrow therapeutic window?
Signup and view all the answers
Which polymorphism in SCN5A has been associated with increased sensitivity to propafenone?
Signup and view all the answers
What major adverse event is associated with the use of flecainide?
Signup and view all the answers
What did the study by Echt et al. (1991) indicate about flecainide?
Signup and view all the answers
What characteristic of SCN5A is mentioned in relation to familial atrial fibrillation?
Signup and view all the answers
What potential effect does propafenone have on ECG patterns?
Signup and view all the answers
In MAPRE KO hiPSC-CMs, what changes were observed?
Signup and view all the answers
Natural differences in biophysical properties of SCN5A are noted between which regions?
Signup and view all the answers
Study Notes
Nav1.5 Biophysical Properties
- Nav1.5 is the pore-forming subunit of the voltage-gated sodium channel in the human heart.
- Nav1.5 is encoded by the SCN5A gene.
- Nav1.5 is responsible for generating the sodium current (INa) in the heart.
Nav1.5 Gating
- Nav1.5 undergoes a series of transitions (gating) to allow sodium ions to flow through the channel.
- These transitions include activation, inactivation, and recovery from inactivation.
Genetic Polymorphisms in SCN5A
- Mutations in SCN5A can lead to various cardiac disorders.
- Long QT Syndrome (LQTS) is caused by gain-of-function mutations in SCN5A, resulting in prolonged action potential duration (APD) and QT interval.
- Brugada Syndrome (BrS) is caused by loss-of-function mutations in SCN5A.
- Early Repolarisation Syndrome, Congenital Sick Sinus Syndrome, Familial Atrial Fibrillation, and Sudden Infant Death Syndrome are other disorders associated with SCN5A polymorphisms.
Brugada Syndrome
- BrS is characterized by a unique ECG pattern and an increased risk of sudden cardiac death.
- New gene, MAPRE2, has been identified as a risk factor for BrS.
- MAPRE2 deficiency leads to reductions in conduction velocity, action potential upstroke velocity, sodium current, and prolonged action potential duration.
Optical Mapping for Cardiac Electrophysiology
- Optical mapping uses fluorescent dyes to visualize and analyze electrical activity in heart cells and tissues.
- It offers a powerful tool for studying arrhythmias and the effects of anti-arrhythmic drugs.
Anti-Arrhythmic Drugs and SCN5A
- Anti-arrhythmic drugs can be challenging to use due to narrow therapeutic windows and potential for pro-arrhythmia.
- Flecainide and propafenone are anti-arrhythmic drugs that can cause adverse events, including prolonged QRS duration, BrS, and cardiogenic shock.
- Flecainide can increase mortality compared to placebo in patients with ventricular arrhythmia.
- Propafenone can induce a BrS-like pattern in individuals with specific SCN5A polymorphisms.
- Certain SCN5A mutations can decrease sensitivity to flecainide, suggesting individual variability in drug responses.
Biophysical Diversity in SCN5A
- There are naturally occurring differences in the biophysical properties of Nav1.5 between left ventricular and right ventricular myocardium.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores the biophysical properties and gating mechanisms of the Nav1.5 sodium channel in the heart. It also covers the genetic polymorphisms in the SCN5A gene and their association with various cardiac disorders such as Long QT Syndrome and Brugada Syndrome. Test your knowledge on how these elements contribute to cardiac function and dysfunction.